-
Entity
-
Individual
-
Location
-
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
-
Summary
-
The estimated net worth of Stephen F. Mahoney is at least $2.43M dollars as of March 4, 2025. Stephen F. Mahoney is the President and CEO, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $2.22M. Stephen F. Mahoney is the Title: Chief Financial and Operating Officer of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $207K.